John H. Rex

Chief Tech/Sci/R&D Officer at

F2G Ltd.

Consumer Services

Health Technology

Finance

Profile

Dr. John H.
Rex, MD, is an Operating Partner at Advent Venture Partners LLP and a Chief Medical Officer & Director at F2G Ltd. He is on the Board of Directors at F2G Ltd. Dr. Rex was previously employed as a Head-Infection & Global Medicines Development by AstraZeneca GmbH and a Vice Chairman by CLSI, Inc. He received his undergraduate degree from William Marsh Rice University and a doctorate degree from Baylor College of Medicine.

John H. Rex active positions

Companies	Position	Start
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment	Chief Tech/Sci/R&D Officer	01/11/2016
Advent Venture Partners LLP Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements.	Consultant / Advisor	31/10/2015

All active positions of John H. Rex

Former positions of John H. Rex

Companies	Position	End
AstraZeneca GmbH AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs	Corporate Officer/Principal	30/09/2016
CLSI, Inc. CLSI, Inc. Information Technology ServicesTechnology Services Provides computer support services	Director/Board Member	-

See the detail of John H. Rex's experience

Training of John H. Rex

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John H. Rex's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Advent Venture Partners LLP Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements.	Finance
Rice University Rice University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CLSI, Inc. CLSI, Inc. Information Technology ServicesTechnology Services Provides computer support services	Technology Services
Baylor College of Medicine Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment	Health Technology
AstraZeneca GmbH AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs	Health Technology